2-(4-Aminopiperidin-1-yl)isonicotinonitrile hydrochloride

Catalog No. :
ACCCMN348
CAS No. :
1185309-64-1
Molecular Formula :
C11H15ClN4
Molecular Weight :
238.72

IUPAC Name:2-(4-aminopiperidin-1-yl)isonicotinonitrile hydrochloride

2-(4-Aminopiperidin-1-yl)isonicotinonitrile hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$302.00Login to see priceInquiryInquiry
250mg95%$422.00Login to see priceInquiryInquiry
1g95%$833.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Aminopiperidin-1-yl)isonicotinonitrile hydrochloride
IUPAC Name2-(4-aminopiperidin-1-yl)isonicotinonitrile hydrochloride
MDL No.MFCD09607855
Molecular FormulaC11H15ClN4
Molecular Weight238.72
SMILESN#CC1=CC=NC(N2CCC(N)CC2)=C1.[H]Cl
InChI KeyPVYLWLYLITVBMJ-UHFFFAOYSA-N
Synonym4-AMino-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72;2-(4-Amino-1-piperidinyl)-4-pyridinecarbonitrile hydrochloride;2-(4-AMINOPIPERIDIN-1-YL)ISONICOTINONITRILE HYDROCHLORIDE
CAS No.1185309-64-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCCMN348 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCCMN348 route product structure diagram
    ACCCMN3481185309-64-1
Inquiry

2. ACCCMN348 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOYSV150 route compound structure diagram
    ACOYSV15010386-27-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCCMN348 route product structure diagram
    ACCCMN3481185309-64-1
Inquiry

Comments (0)